Literature DB >> 24855275

A defined, controlled culture system for primary bovine chromaffin progenitors reveals novel biomarkers and modulators.

Jimmy Masjkur1, Ian Levenfus1, Sven Lange1, Carina Arps-Forker1, Steve Poser1, Nan Qin1, Vladimir Vukicevic1, Triantafyllos Chavakis1, Graeme Eisenhofer1, Stefan R Bornstein1, Monika Ehrhart-Bornstein1, Andreas Androutsellis-Theotokis2.   

Abstract

We present a method to efficiently culture primary chromaffin progenitors from the adult bovine adrenal medulla in a defined, serum-free monolayer system. Tissue is dissociated and plated for expansion under support by the mitogen basic fibroblast growth factor (bFGF). The cultures, although not homogenous, contain a subpopulation of cells expressing the neural stem cell marker Hes3 that also propagate. In addition, Hes3 is also expressed in the adult adrenal medulla from where the tissue is taken. Differentiation is induced by bFGF withdrawal and switching to Neurobasal medium containing B27. Following differentiation, Hes3 expression is lost, and cells acquire morphologies and biomarker expression patterns of chromaffin cells and dopaminergic neurons. We tested the effect of different treatments that we previously showed regulate Hes3 expression and cell number in cultures of fetal and adult rodent neural stem cells. Treatment of the cultures with a combination of Delta4, Angiopoietin2, and a Janus kinase inhibitor increases cell number during the expansion phase without significantly affecting catecholamine content levels. Treatment with cholera toxin does not significantly affect cell number but reduces the ratio of epinephrine to norepinephrine content and increases the dopamine content relative to total catecholamines. These data suggest that this defined culture system can be used for target identification in drug discovery programs and that the transcription factor Hes3 may serve as a new biomarker of putative adrenomedullary chromaffin progenitor cells. ©AlphaMed Press.

Entities:  

Keywords:  Cell culture; Differentiation; Self-renewal; Signal transduction

Mesh:

Substances:

Year:  2014        PMID: 24855275      PMCID: PMC4073824          DOI: 10.5966/sctm.2013-0211

Source DB:  PubMed          Journal:  Stem Cells Transl Med        ISSN: 2157-6564            Impact factor:   6.940


  34 in total

1.  Simultaneous liquid-chromatographic determination of 3,4-dihydroxyphenylglycol, catecholamines, and 3,4-dihydroxyphenylalanine in plasma, and their responses to inhibition of monoamine oxidase.

Authors:  G Eisenhofer; D S Goldstein; R Stull; H R Keiser; T Sunderland; D L Murphy; I J Kopin
Journal:  Clin Chem       Date:  1986-11       Impact factor: 8.327

2.  Action of cholera toxin to stimulate adenyl cyclase.

Authors:  G W Sharp; S Hynie; L C Lipson; D K Parkinson
Journal:  Trans Assoc Am Physicians       Date:  1971

3.  A bipotential neuroendocrine precursor whose choice of cell fate is determined by NGF and glucocorticoids.

Authors:  D J Anderson; R Axel
Journal:  Cell       Date:  1986-12-26       Impact factor: 41.582

4.  Nerve growth factor-induced neurite outgrowth from normal human chromaffin cells.

Authors:  A S Tischler; R A DeLellis; B Biales; G Nunnemacher; V Carabba; H J Wolfe
Journal:  Lab Invest       Date:  1980-11       Impact factor: 5.662

5.  Cholera toxin does not prevent neurite outgrowth from adult human chromaffin cells in culture.

Authors:  A S Tischler; V W Slayton
Journal:  Exp Cell Res       Date:  1983-02       Impact factor: 3.905

6.  Opposing effects of HIF1α and HIF2α on chromaffin cell phenotypic features and tumor cell proliferation: Insights from MYC-associated factor X.

Authors:  Nan Qin; Aguirre A de Cubas; Ruben Garcia-Martin; Susan Richter; Mirko Peitzsch; Mario Menschikowski; Jacques W M Lenders; Henri J L M Timmers; Massimo Mannelli; Giuseppe Opocher; Matina Economopoulou; Gabriele Siegert; Triantafyllos Chavakis; Karel Pacak; Mercedes Robledo; Graeme Eisenhofer
Journal:  Int J Cancer       Date:  2014-04-07       Impact factor: 7.396

7.  Effects of cell culture conditions, nerve growth factor, dexamethasone, and cyclic AMP on adrenal chromaffin cells in vitro.

Authors:  K Unsicker; B Rieffert; W Ziegler
Journal:  Adv Biochem Psychopharmacol       Date:  1980

Review 8.  Cell transplantation for Parkinson's disease: present status.

Authors:  René Drucker-Colín; Leticia Verdugo-Díaz
Journal:  Cell Mol Neurobiol       Date:  2004-06       Impact factor: 5.046

9.  Differential effects of cyclic AMP and cholera toxin on nerve growth factor-induced neurite outgrowth from adrenal medullary chromaffin and pheochromocytoma cells.

Authors:  W Ziegler; K Unsicker
Journal:  Brain Res       Date:  1981-07       Impact factor: 3.252

10.  Selective inhibition of responses to nerve growth factor and of microtubule-associated protein phosphorylation by activators of adenylate cyclase.

Authors:  L A Greene; S A Drexler; J L Connolly; A Rukenstein; S H Green
Journal:  J Cell Biol       Date:  1986-11       Impact factor: 10.539

View more
  2 in total

Review 1.  Concise Review: Reprogramming, Behind the Scenes: Noncanonical Neural Stem Cell Signaling Pathways Reveal New, Unseen Regulators of Tissue Plasticity With Therapeutic Implications.

Authors:  Steven W Poser; Josh G Chenoweth; Carlo Colantuoni; Jimmy Masjkur; George Chrousos; Stefan R Bornstein; Ronald D McKay; Andreas Androutsellis-Theotokis
Journal:  Stem Cells Transl Med       Date:  2015-09-14       Impact factor: 6.940

2.  Streptozotocin-induced β-cell damage, high fat diet, and metformin administration regulate Hes3 expression in the adult mouse brain.

Authors:  Polyxeni Nikolakopoulou; Antonios Chatzigeorgiou; Ioannis Kourtzelis; Louiza Toutouna; Jimmy Masjkur; Carina Arps-Forker; Steven W Poser; Jan Rozman; Birgit Rathkolb; Juan Antonio Aguilar-Pimentel; Eckhard Wolf; Martin Klingenspor; Markus Ollert; Carsten Schmidt-Weber; Helmut Fuchs; Valerie Gailus-Durner; Martin Hrabe de Angelis; Vasiliki Tsata; Laura Sebastian Monasor; Maria Troullinaki; Anke Witt; Vivian Anastasiou; George Chrousos; Chun-Xia Yi; Cristina García-Cáceres; Matthias H Tschöp; Stefan R Bornstein; Andreas Androutsellis-Theotokis
Journal:  Sci Rep       Date:  2018-07-27       Impact factor: 4.379

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.